May 23, 2018 - Read up on upcoming potentially actionable events for the mid- to long-term coming out of 2018's biggest cancer meeting.Puma's drug seems to work a lot better if you can handle it for a long stretch.T
May 23, 2018 -
Celgene Corporation (NASDAQ: CELG) is down about 35 percent year-over-year, and as management resists challenges to critical Revlimid patents, analysts are at odds about where the stock could head from here.
May 23, 2018 - Celgene's stock is in a downtrend but selling volume picked up on May 21 for no apparent reason.Investor confidence in management is lacking.Valuation multiples imply a deep discount.
May 22, 2018 - A list of the top 10 stocks in terms of total volume traded that also had insider buying. We provide in-depth analysis and ratings of each transaction. Only insider transactions that were executed on
May 22, 2018 - Recent weakness in the biotech sector is an opportunity to add to conviction holdings.My ¨Week in Review¨ blog post appears to have the makings of a permanent feature due to positive feedback received
May 22, 2018 -
Celgene Corporation (NASDAQ: CELG) — which is recently very much in the news, although for dubious reasons — has struck a read more
May 21, 2018 - John Carroll reports that Celgene's (CELG -4.3%) business development head George Golumbeski quietly ended his nine-year stint at the biotech last month. His departure, mutually amicable according to
May 21, 2018 - Main Small-Cap Index Russell 2000 Rallies to Record, Stocks: CELG,SYMC,MAT,NUE.HAS,MNRO,MU,BA,INTC,FL,CAT, release date:May 21, 2018
May 21, 2018 - The FDA calls out Celgene, Actelion, Novartis, Gilead and other branded drug makers for anti-competitive behavior.Jeff Miller’s “Weighing the Week Ahead” takes on the fear that rising interest rates s
May 21, 2018 - Investing in quality stocks can be remarkably profitable in the long term.Quality can be hard to define, but some quantitative indicators are clear signs of underlying fundamental quality.Introducing